Myrexis Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

-67.94%

Revenues

Net income

-12m

L-62.76%

CFO

-13m

L-53.29%

Dividend

Feb 19, 20132.86 USD/sh

Profile

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

URL

https://myrexis.com/

IPO date

Jun 12, 2009

Employees

Domiciled in

Incorporated in

Valuation

No data to show